Results 21 to 30 of about 14,789 (299)

RP-HPLC method development and validation for simultaneous estimation of mesalamine and curcumin in bulk form as well as nanostructured lipid carriers

open access: hybridSouth African Journal of Botany, 2022
A. Awasthi   +16 more
semanticscholar   +2 more sources

Drug-Induced Intersticial Nephritis. Clinical Case

open access: yesActa Medica Lituanica, 2021
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects.
Paulina Tekoriutė   +2 more
doaj   +1 more source

Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. [PDF]

open access: yesPLoS ONE, 2018
Mesalamine is commonly used to treat ulcerative colitis (UC). Although mesalamine acts topically, in vitro data suggest that intracellular transport is required for its beneficial effect.
Christopher J Moran   +5 more
doaj   +1 more source

Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.

open access: yesClinical Gastroenterology and Hepatology, 2023
BACKGROUND & AIMS Some patients with irritable bowel syndrome (IBS) demonstrate low-grade inflammation in the intestine. Mesalamine, which has anti-inflammatory effects, may be an efficacious treatment for IBS, but studies are conflicting. We conducted a
Vivek C. Goodoory   +3 more
semanticscholar   +1 more source

Exacerbation of Bloody Diarrhea as a Side Effect of Mesalamine Treatment of Active Ulcerative Colitis

open access: yesCase Reports in Gastroenterology, 2011
Mesalamine has been used as the first-line therapy for the treatment of ulcerative colitis (UC) because of its efficacy and fewer side effects. However, earlier study showed that mesalamine occasionally causes diarrhea.
Yuichi Shimodate   +5 more
doaj   +1 more source

Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C. [PDF]

open access: yes, 2015
Sofosbuvir and simeprevir are used for the treatment of chronic hepatitis C (HCV) genotype 1. Both drugs have been well-tolerated, with diarrhea noted in 6% cases with sofosbuvir, 16% with sofosbuvir plus simeprevir, and 0% with simeprevir.
Jakab, Simona   +4 more
core   +1 more source

Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn’s disease [PDF]

open access: yes, 2014
Background Crohn’s disease (CD) is a chronic relapsing inflammatory condition. Many patients fail to achieve remission with medical management and require surgical interventions.
Angelberger   +41 more
core   +1 more source

Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine

open access: yesCureus, 2023
Inflammation of the myocardium (myocarditis), pericardium (pericarditis), or both (myopericarditis) is a rare but potentially lethal side effect of mesalamine, a drug widely used in the treatment of inflammatory bowel disease (IBD).
Pratul Karki   +3 more
semanticscholar   +1 more source

Mesalamine Associated Bradycardia [PDF]

open access: yesCureus, 2018
A 38-year-old female presented with an acute flare of ulcerative colitis. She was started on prednisone and mesalamine. Within 24 hours of initiating mesalamine, she developed sinus bradycardia. After holding mesalamine, the heart rate returned to normal within five days.
Krzyzak, Michael   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy